Gemcitabine and Irinotecan in Treating Patients With Metastatic Kidney Cancer

Summary

RATIONALE: Drugs used in chemotherapy, such as gemcitabine and irinotecan, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. PURPOSE: This phase II trial is studying the side effects and how well giving gemcitabine together with irinotecan works in treating patients with metastatic kidney cancer.

Timeline

Start

2004-05

Primary completion

2007-02

Completion

2007-02

Drugs

Indications